GRTX Insider Trading - Galera Therapeutics, Inc.

Deler fremragende	75,462,390 shares
Insideraktier	42.263.405 shares
Insider ejerskab	56,01 %
Total Insiders	52

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

6276 out of 10998

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )

6176 out of 10864

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Galera Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
Lawrence M Alleva Director - [D]	2.325	2.325
Altamont Pharmaceutical Holdings, LLC 10% Owner - [10%]	1.080.000	1.080.000
Peter J Barris 10% Owner - [10%]	4.358.047	4.358.047
Forest Baskett 10% Owner - [10%]	4.358.047	4.358.047
Mark Bachleda Chief Commercial Officer - [O]	11.000	11.000
Robert A Beardsley Chief Operating Officer - [O]	108.191	108.191
Blackstone Clarus GP L.L.C. 10% Owner - [10%]	130.444	130.444
Blackstone Clarus GP L.P. 10% Owner - [10%]	130.444	130.444
Blackstone Group L.P. 10% Owner - [10%]	130.444	130.444
Blackstone Group Management L.L.C. 10% Owner - [10%]	130.444	130.444
Blackstone Holdings I/II GP Inc 10% Owner - [10%]	130.444	130.444
Blackstone Holdings II L.P. 10% Owner - [10%]	130.444	130.444
Buckler Regina A. 10% Owner - [10%]	108.516	108.516
Nancy T Chang Director, 10% Owner - [D] [10%]	8.825.543	8.825.543
Clarus IV GP L.P. 10% Owner - [10%]	130.444	130.444
Clarus IV-A, L.P. 10% Owner - [10%]	130.444	130.444
Clarus IV-B, L.P. 10% Owner - [10%]	130.444	130.444

Insider	Aktier Ejet	Dele Justeret
Clarus IV-C, L.P. 10% Owner - [10%]	130.444	130.444
Clarus IV-D, L.P. 10% Owner - [10%]	130.444	130.444
Emmett Cunningham	0
Chris Degnan Chief Financial Officer - [O]	10.000	10.000
Friedman Michael R. Director - [D]	5.336.870	5.336.870
Florence Anthony A. Jr. 10% Owner - [10%]	4.358.047	4.358.047
Arthur Fratamico	74.435
Jason Fuller	19.776
James Healy 10% Owner - [10%]	3.083.712	3.083.712
Jon T Holmlund Chief Medical Officer - [O]	0	0
Patrick J Kerins 10% Owner - [10%]	4.358.047	4.358.047
Jeffrey Keene 10% Owner - [10%]	108.516	108.516
Kevin G Lokay	9.888
David M Mott 10% Owner - [10%]	4.358.047	4.358.047
Matthes Catherine L. 10% Owner - [10%]	105.660	105.660
Anand Mehra 10% Owner - [10%]	3.083.712	3.083.712
Nea 14 Gp, Ltd 10% Owner - [10%]	4.358.047	4.358.047

Insider	Aktier Ejet	Dele Justeret
NEA Partners 14, L.P. 10% Owner - [10%]	4.358.047	4.358.047
Ag Novartis 10% Owner - [10%]	2.467.961	2.467.961
New Enterprise Associates 14, L.P. 10% Owner - [10%]	4.358.047	4.358.047
Bioventures Ltd Novartis -	2.467.961	2.467.961
A/S Novo 10% Owner - [10%]	2.459.021	2.459.021
Michael Powell Director, 10% Owner - [D] [10%]	13.179	3.083.712
Dennis Riley 10% Owner - [10%]	108.516	108.516
Scott D Sandell 10% Owner - [10%]	4.358.047	4.358.047
Stephen A Schwarzman 10% Owner - [10%]	130.444	130.444
Yair Schneid 10% Owner - [10%]	10.823.610	10.823.610
Rochel Soffer 10% Owner - [10%]	2.750.000	2.750.000
Sofinnova Management IX, L.L.C. 10% Owner - [10%]	3.083.712	3.083.712
Sofinnova Venture Partners IX, L.P. 10% Owner - [10%]	3.083.712	3.083.712
Sonsini Peter W. 10% Owner - [10%]	4.358.047	4.358.047
Mel Sorensen President and CEO, Director - [D] [O]	195.029	195.029
Jennifer Evans Stacey	75.000
Sussman Joel F. Chief Accounting Officer - [O]	0	0
Linda West Director - [D]	60.000	60.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GRTX / Galera Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks
2024-12-30	CHANG NANCY T	7.644.932	0,0654	7.644.932	0,0654	499.979	730
2024-04-19	Schneid Yair	100	0,1855	100	0,1855	19
2024-04-19	Schneid Yair	314	0,1874	314	0,1874	59
2024-04-19	Schneid Yair	215	0,1875	215	0,1875	40
2024-04-19	Schneid Yair	99.371	0,1940	99.371	0,1940	19.278
2024-04-18	Schneid Yair	17.211	0,1850	17.211	0,1850	3.184
2024-04-18	Schneid Yair	100.000	0,1893	100.000	0,1893	18.930
2024-04-18	Schneid Yair	100.000	0,1970	100.000	0,1970	19.700
2024-04-18	Schneid Yair	247.600	0,1980	247.600	0,1980	49.025

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GRTX / Galera Therapeutics, Inc. Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GRTX / Galera Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min
2025-11-20	Sorensen Mel	70.000	0,0201	70.000	0,0201	1.407	730
2024-08-16	Sorensen Mel	67.015	0,0720	67.015	0,0720	4.825
2024-03-28	Altamont Pharmaceutical Holdings, LLC	693.076	0,1459	693.076	0,1459	101.120
2024-03-27	Altamont Pharmaceutical Holdings, LLC	306.924	0,1699	306.924	0,1699	52.146
2024-03-26	Altamont Pharmaceutical Holdings, LLC	2.000.000	0,1965	2.000.000	0,1965	393.000
2024-03-25	Altamont Pharmaceutical Holdings, LLC	780.000	0,2189	780.000	0,2189	170.742
2024-03-22	Altamont Pharmaceutical Holdings, LLC	20.000	0,2300	20.000	0,2300	4.600
2024-01-11	Altamont Pharmaceutical Holdings, LLC	400.000	0,2256	400.000	0,2256	90.240
2021-02-18	Novo A/S	500.000	10,5800	500.000	10,5800	5.290.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2026-04-09	2026-04-07	4	FRIEDMAN MICHAEL R.	GRTX	Common Stock	C - Conversion	I			5.336.870			5.336.870
2026-04-09	2026-04-07	4	CHANG NANCY T	GRTX	Common Stock	C - Conversion	D			1.180.611			8.825.543
2025-11-24	2025-11-20	4	Sorensen Mel	GRTX	Common Stock	S - Sale	D		0,0201	-70.000	-1		195.029
2025-01-02	2024-12-30	4	CHANG NANCY T	GRTX	Common Stock	P - Purchase	D		0,0654	7.644.932	500		7.644.932
2024-08-20	2024-08-16	4	Sorensen Mel	GRTX	Common Stock	S - Sale	D		0,0720	-67.015	-5		265.029
2024-05-16		3	Soffer Rochel	GRTX	Common Stock		D						3.178.137
2024-05-16		3	Soffer Rochel	GRTX	Common Stock		I						2.750.000
2024-05-01	2024-04-19	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1940	99.371	19		10.823.610
2024-05-01	2024-04-19	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1875	215	0		10.724.239
2024-05-01	2024-04-19	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1874	314	0		10.724.024
2024-05-01	2024-04-19	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1855	100	0		10.723.710
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2000	74.202	15		10.723.610
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1999	4.342	1		10.649.408
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1998	4.245	1		10.645.066
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1980	247.600	49		10.640.821
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1970	100.000	20		10.393.221
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1893	100.000	19		10.293.221
2024-05-01	2024-04-18	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1850	17.211	3		10.193.221
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2400	453.988	109		10.176.010
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2300	551.217	127		9.722.022
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2200	243.100	53		9.170.805
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2140	50.000	11		8.927.705
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2120	50.000	11		8.877.705
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2100	56.900	12		8.827.705
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2000	241.028	48		8.770.805
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1960	68.424	13		8.529.777
2024-05-01	2024-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1910	100.000	19		8.461.353
2024-05-01	2014-04-17	4/A	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1900	318.150	60		8.361.353
2024-04-01	2024-03-28	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,1459	-693.076	-101		1.080.000
2024-04-01	2024-03-27	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,1699	-306.924	-52		1.773.076
2024-04-01	2024-03-26	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,1965	-2.000.000	-393		2.080.000
2024-04-01	2024-03-25	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,2189	-780.000	-171		4.080.000
2024-04-01	2024-03-22	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,2300	-20.000	-5		4.860.000
2024-04-01	2024-01-11	5	Altamont Pharmaceutical Holdings, LLC See fn.	GRTX	Common Stock	S - Sale	I		0,2256	-400.000	-90		4.880.000
2024-02-26	2024-02-08	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1710	150.000	26		8.043.203
2024-02-26	2024-02-07	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1729	150.000	26		7.893.203
2024-02-26	2024-02-07	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1700	25.000	4		7.743.203
2024-02-26	2024-02-06	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,2010	25.000	5		7.718.203
2024-02-26	2024-02-05	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1840	97.402	18		7.693.203
2024-02-26	2024-01-30	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1810	335.000	61		7.595.801
2024-02-26	2024-01-29	4	Schneid Yair	GRTX	Common Stock	P - Purchase	D		0,1800	150.000	27		7.260.801
2024-01-16		3	Schneid Yair	GRTX	Common Stock		D						7.110.801
2023-11-13		3	Altamont Pharmaceutical Holdings, LLC	GRTX	Common Stock		I						5.280.000
2023-03-20	2023-03-16	4	Bachleda Mark	GRTX	Common Stock	P - Purchase	D		2,2470	11.000	25		11.000
2023-03-14	2023-03-13	4	Degnan Chris	GRTX	Common Stock	P - Purchase	D		1,9593	10.000	20		10.000
2023-03-14	2023-03-10	4	Sorensen Mel	GRTX	Common Stock	P - Purchase	D		1,6812	100.000	168		332.044
2022-11-22	2022-11-21	4	Beardsley Robert A	GRTX	Common Stock	M - Exercise	D		1,0700	10.000	11		108.191
2022-09-13	2022-09-12	4	Beardsley Robert A	GRTX	Common Stock	M - Exercise	D		1,0700	10.000	11		98.191
2022-07-20	2022-07-18	4	Alleva Lawrence M	GRTX	Common Stock	G - Gift	D			-4.000			2.325
2022-03-02	2022-02-28	4	Degnan Chris	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		135.000		135.000
2022-03-02	2022-02-28	4	HOLMLUND JON T	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		75.000		75.000
2022-03-02	2022-02-28	4	Bachleda Mark	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		75.000		75.000
2022-03-02	2022-02-28	4	Stacey Jennifer Evans	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		75.000		75.000
2022-03-02	2022-02-28	4	Beardsley Robert A	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		75.000		75.000
2022-03-02	2022-02-28	4	Sorensen Mel	GRTX	Stock Option (Right to Buy)	A - Award	D	2,24		264.400		264.400
2021-12-20	2021-12-17	4	Beardsley Robert A	GRTX	Stock Option	M - Exercise	D	1,07		-20.000		95.651
2021-12-20	2021-12-17	4	Beardsley Robert A	GRTX	Common Stock	M - Exercise	D		1,0700	20.000	21		88.191
2021-12-20	2021-12-17	4	West Linda	GRTX	Common Stock	P - Purchase	D		2,7402	20.000	55		60.000
2021-10-12	2021-10-08	4	Stacey Jennifer Evans	GRTX	Stock Option (Right to Buy)	A - Award	D	7,84		130.000		130.000
2021-10-12	2021-10-08	4	Bachleda Mark	GRTX	Stock Option (Right to Buy)	A - Award	D	7,84		200.000		200.000
2021-09-03	2021-09-01	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	2,43		-47.756		61.142
2021-09-03	2021-09-01	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		8,4701	-47.756	-404		0
2021-09-03	2021-09-01	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		2,4300	47.756	116		47.756
2021-07-06	2021-07-01	4	Alleva Lawrence M	GRTX	Stock Option (Right to Buy)	A - Award	D	10,09		8.498		8.498
2021-07-06	2021-07-01	4	Cunningham Emmett	GRTX	Stock Option (Right to Buy)	A - Award	D	10,09		5.408		0
2021-07-06	2021-07-01	4	West Linda	GRTX	Stock Option (Right to Buy)	A - Award	D	10,09		8.730		8.730
2021-06-17	2021-06-16	4	LOKAY KEVIN G	GRTX	Stock Option (Right to Buy)	A - Award	D	8,90		9.888		9.888
2021-06-17	2021-06-16	4	West Linda	GRTX	Stock Option (Right to Buy)	A - Award	D	8,90		9.888		9.888
2021-06-17	2021-06-15	4	West Linda	GRTX	Common Stock	P - Purchase	D		9,1300	10.000	91		40.000
2021-06-17	2021-06-16	4	Alleva Lawrence M	GRTX	Stock Option (Right to Buy)	A - Award	D	8,90		9.888		9.888
2021-06-17	2021-06-16	4	POWELL MICHAEL	GRTX	Stock Option (Right to Buy)	A - Award	D	8,90		13.179		13.179
2021-06-17	2021-06-16	4	Cunningham Emmett	GRTX	Stock Option (Right to Buy)	A - Award	D	8,90		9.888		0
2021-06-04	2021-06-02	4	West Linda	GRTX	Common Stock	P - Purchase	D		8,6511	10.000	87		30.000
2021-06-03	2021-06-01	4	Alleva Lawrence M By the Lawrence M. Alleva Revocable Trust.	GRTX	Common Stock	P - Purchase	I		8,5887	4.045	35		4.045
2021-06-02	2021-06-01	4	West Linda	GRTX	Common Stock	P - Purchase	D		8,6381	10.000	86		20.000
2021-06-02	2021-05-28	4	West Linda	GRTX	Common Stock	P - Purchase	D		8,6410	10.000	86		10.000
2021-03-30	2021-03-26	4	Sorensen Mel	GRTX	Stock Option (Right to Buy)	M - Exercise	D	1,14		-46.940		0
2021-03-30	2021-03-26	4	Sorensen Mel	GRTX	Stock Option (Right to Buy)	M - Exercise	D	1,07		-170.075		0
2021-03-30	2021-03-26	4	Sorensen Mel	GRTX	Common Stock	M - Exercise	D		1,1400	46.940	54		232.044
2021-03-30	2021-03-26	4	Sorensen Mel	GRTX	Common Stock	M - Exercise	D		1,0700	170.075	182		185.104
2021-02-19	2021-02-18	4	Novo A/S	GRTX	COMMON STOCK	S - Sale	D		10,5800	-500.000	-5.290		2.459.021
2021-01-28	2021-01-26	4	Sorensen Mel	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		190.000		190.000
2021-01-28	2021-01-26	4	Fratamico Arthur	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		75.000		75.000
2021-01-28	2021-01-26	4	Beardsley Robert A	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		75.000		75.000
2021-01-28	2021-01-26	4	HOLMLUND JON T	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		71.250		71.250
2021-01-28	2021-01-26	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		50.000		50.000
2021-01-28	2021-01-26	4	Degnan Chris	GRTX	Stock Option (Right to Buy)	A - Award	D	11,99		82.500		82.500
2020-11-17	2020-11-13	4	Alleva Lawrence M	GRTX	Common Stock	P - Purchase	D		10,2242	2.325	24		6.325
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	M - Exercise	D	2,43		-2.639		32.238
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	M - Exercise	D	1,14		-3.755		0
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	M - Exercise	D	1,07		-3.606		0
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Common Stock	S - Sale	D		10,3197	-10.000	-103		0
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Common Stock	M - Exercise	D		2,4300	2.639	6		10.000
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Common Stock	M - Exercise	D		1,1400	3.755	4		7.361
2020-11-16	2020-11-13	4	Sussman Joel F.	GRTX	Common Stock	M - Exercise	D		1,0700	3.606	4		3.606
2020-11-16	2020-11-12	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	M - Exercise	D	1,07		-10.000		3.606
2020-11-16	2020-11-12	4	Sussman Joel F.	GRTX	Common Stock	S - Sale	D		10,0627	-10.000	-101		0
2020-11-16	2020-11-12	4	Sussman Joel F.	GRTX	Common Stock	M - Exercise	D		1,0700	10.000	11		10.000
2020-10-28	2020-10-26	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	2,43		-2.244		108.898
2020-10-28	2020-10-26	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		15,0000	-2.244	-34		0
2020-10-28	2020-10-26	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		2,4300	2.244	5		2.244
2020-10-19	2020-10-15	4	Novo A/S	GRTX	COMMON STOCK	S - Sale	D		11,0000	-450.000	-4.950		2.959.021
2020-10-07	2020-10-06	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,14		-5.632		0
2020-10-07	2020-10-06	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-4.904		0
2020-10-07	2020-10-06	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-10.536	-126		0
2020-10-07	2020-10-06	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,1400	5.632	6		5.632
2020-10-07	2020-10-06	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	4.904	5		4.904
2020-10-07	2020-10-05	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-100		4.904
2020-10-07	2020-10-05	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-100	-1		0
2020-10-07	2020-10-05	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	100	0		100
2020-06-22	2020-06-19	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		8,2500	-1.001.312	-8.261		2.467.961
2020-06-22	2020-06-18	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,0400	-900	-8		3.469.273
2020-06-17	2020-06-17	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,2700	-4.622	-43		3.470.173
2020-06-17	2020-06-16	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,3000	-8.600	-80		3.474.795
2020-06-17	2020-06-15	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,0500	-6.164	-56		3.483.395
2020-06-12	2020-06-12	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,1900	-1.500	-14		3.489.559
2020-06-12	2020-06-11	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,2100	-7.200	-66		3.491.059
2020-06-12	2020-06-10	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,4600	-8.532	-81		3.498.259
2020-06-10	2020-06-09	4	LOKAY KEVIN G	GRTX	Stock Option (Right to Buy)	A - Award	D	9,31		9.888		9.888
2020-06-10	2020-06-09	4	Alleva Lawrence M	GRTX	Stock Option (Right to Buy)	A - Award	D	9,31		9.888		9.888
2020-06-10	2020-06-09	4	POWELL MICHAEL	GRTX	Stock Option (Right to Buy)	A - Award	I	9,31		13.179		13.179
2020-06-10	2020-06-09	4	Cunningham Emmett	GRTX	Stock Option (Right to Buy)	A - Award	D	9,31		9.888		0
2020-06-09	2020-06-09	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,3800	-7.000	-66		3.506.791
2020-06-09	2020-06-08	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,6600	-5.659	-55		3.513.791
2020-06-09	2020-06-05	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,6600	-8.652	-84		3.519.450
2020-06-04	2020-06-04	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,5500	-4.088	-39		3.528.102
2020-06-04	2020-06-03	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,7800	-5.208	-51		3.532.190
2020-06-04	2020-06-02	4	Novartis Bioventures Ltd	GRTX	Common Stock	S - Sale	D		9,6800	-5.669	-55		3.537.398
2020-05-28	2020-05-26	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-692		5.004
2020-05-28	2020-05-26	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-692	-8		0
2020-05-28	2020-05-26	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	692	1		692
2020-05-22	2020-05-21	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-1.174		5.696
2020-05-22	2020-05-21	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-1.174	-14		0
2020-05-22	2020-05-21	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	1.174	1		1.174
2020-05-22	2020-05-20	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-969		6.870
2020-05-22	2020-05-20	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-969	-12		0
2020-05-22	2020-05-20	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	969	1		969
2020-05-12	2020-05-12	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-671		7.839
2020-05-12	2020-05-12	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-671	-8		0
2020-05-12	2020-05-12	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	671	1		671
2020-05-12	2020-05-11	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-185		8.510
2020-05-12	2020-05-11	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-185	-2		0
2020-05-12	2020-05-11	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	185	0		185
2020-05-12	2020-05-08	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-5.102		8.695
2020-05-12	2020-05-08	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-5.102	-61		0
2020-05-12	2020-05-08	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	5.102	5		5.102
2020-05-07	2020-05-07	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-2.059		13.797
2020-05-07	2020-05-07	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0007	-2.059	-25		0
2020-05-07	2020-05-07	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	2.059	2		2.059
2020-05-07	2020-05-06	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-1.489		15.856
2020-05-07	2020-05-06	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,0000	-1.489	-18		0
2020-05-07	2020-05-06	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	1.489	2		1.489
2020-05-07	2020-05-05	4	HOLMLUND JON T	GRTX	Stock Option	M - Exercise	D	1,07		-3.064		17.345
2020-05-07	2020-05-05	4	HOLMLUND JON T	GRTX	Common Stock	S - Sale	D		12,1600	-3.064	-37		0
2020-05-07	2020-05-05	4	HOLMLUND JON T	GRTX	Common Stock	M - Exercise	D		1,0700	3.064	3		3.064
2020-04-02	2020-03-31	4	West Linda	GRTX	Stock Option (Right to Buy)	A - Award	D	9,50		19.776		19.776
2020-02-04	2020-01-31	4	Beardsley Robert A	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		74.435		74.435
2020-02-04	2020-01-31	4	Riley Dennis	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		74.435		74.435
2020-02-04	2020-01-31	4	Sorensen Mel	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		186.087		186.087
2020-02-04	2020-01-31	4	Degnan Chris	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		74.435		74.435
2020-02-04	2020-01-31	4	Fratamico Arthur	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		74.435		74.435
2020-02-04	2020-01-31	4	Sussman Joel F.	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		49.263		49.623
2020-02-04	2020-01-31	4	HOLMLUND JON T	GRTX	Stock Option (Right to Buy)	A - Award	D	14,84		74.435		74.435
2019-12-17	2019-12-13	4	Alleva Lawrence M	GRTX	Common Stock	P - Purchase	D		9,7847	4.000	39		4.000
2019-11-14	2019-11-12	4	Novo A/S	GRTX	SERIES C PREFERRED STOCK	C - Conversion	D			-2.709.659		0
2019-11-14	2019-11-12	4	Novo A/S	GRTX	SERIES B PREFERRED STOCK	C - Conversion	D			-12.000.000		0
2019-11-14	2019-11-12	4	Novo A/S	GRTX	COMMON STOCK	P - Purchase	D		12,0000	500.000	6.000		3.409.021
2019-11-14	2019-11-12	4	Novo A/S	GRTX	COMMON STOCK	C - Conversion	D			535.869			2.909.021
2019-11-14	2019-11-12	4	Novo A/S	GRTX	COMMON STOCK	C - Conversion	D			2.373.152			2.373.152
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-561.385		0
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-2.807.372		0
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-1.552.035		0
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-2.334.966		0
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	19.423	233		130.444
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	97.131	1.166		652.324
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	52.660	632		353.661
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	80.786	969		542.555
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			111.021			111.021
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			555.193			555.193
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			301.001			301.001
2019-11-14	2019-11-12	4	Blackstone Clarus GP L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			461.769			461.769
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-561.385		0
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-2.807.372		0
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-1.552.035		0
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Series C Redeemable Convertible Preferred Stock	C - Conversion	I			-2.334.966		0
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	19.423	233		130.444
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	97.131	1.166		652.324
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	52.660	632		353.661
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	P - Purchase	I		12,0000	80.786	969		542.555
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			111.021			111.021
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			555.193			555.193
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			301.001			301.001
2019-11-14	2019-11-12	4	Clarus IV-A, L.P. See Footnotes	GRTX	Common Stock	C - Conversion	I			461.769			461.769
2019-11-12	2019-11-12	4	Sofinnova Venture Partners IX, L.P.	GRTX	Series C Preferred Stock	C - Conversion	D			-2.709.659		0
2019-11-12	2019-11-12	4	Sofinnova Venture Partners IX, L.P.	GRTX	Series B-2 Preferred Stock	C - Conversion	D			-9.090.909		0
2019-11-12	2019-11-12	4	Sofinnova Venture Partners IX, L.P.	GRTX	Common Stock	P - Purchase	D		12,0000	750.000	9.000		3.083.712
2019-11-12	2019-11-12	4	Sofinnova Venture Partners IX, L.P.	GRTX	Common Stock	C - Conversion	D			2.333.712			2.333.712
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Series C Preferred Stock	C - Conversion	D			-1.354.829		0
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Series B Preferred Stock	C - Conversion	D			-9.600.000		0
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Series A Preferred Stock	C - Conversion	D			-8.975.000		0
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Common Stock	P - Purchase	D		12,0000	416.666	5.000		4.358.047
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Common Stock	C - Conversion	D			267.935			3.941.381
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Common Stock	C - Conversion	D			1.898.524			3.673.446
2019-11-12	2019-11-12	4	New Enterprise Associates 14, L.P.	GRTX	Common Stock	C - Conversion	D			1.774.922			1.774.922
2019-11-12	2019-11-12	4	Beardsley Robert A	GRTX	Series C Preferred Stock	C - Conversion	D			-6.774		0
2019-11-12	2019-11-12	4	Beardsley Robert A	GRTX	Series B Preferred Stock	C - Conversion	D			-2.000		0
2019-11-12	2019-11-12	4	Beardsley Robert A	GRTX	Series A Preferred Stock	C - Conversion	D			-68.907		0
2019-11-12	2019-11-12	4	Beardsley Robert A	GRTX	Common Stock	C - Conversion	D			15.361			68.191
2019-11-12	2019-11-12	4	Novartis Bioventures Ltd	GRTX	Series C Preferred Stock	C - Conversion	I			-451.609		0
2019-11-12	2019-11-12	4	Novartis Bioventures Ltd	GRTX	Series B Preferred Stock	C - Conversion	I			-7.200.000		0
2019-11-12	2019-11-12	4	Novartis Bioventures Ltd	GRTX	Series A Preferred Stock	C - Conversion	I			-9.000.000		0
2019-11-12	2019-11-12	4	Novartis Bioventures Ltd	GRTX	Common Stock	P - Purchase	I		12,0000	250.000	3.000		3.543.067
2019-11-12	2019-11-12	4	Novartis Bioventures Ltd	GRTX	Common Stock	C - Conversion	I			3.293.067			3.293.067
2019-11-08	2019-11-06	4	Degnan Chris	GRTX	Stock Option	A - Award	D	12,00		229.513		229.513
2019-11-08	2019-11-06	4	POWELL MICHAEL	GRTX	Stock Option	A - Award	I	12,00		19.776		19.776
2019-11-08	2019-11-06	4	Cunningham Emmett	GRTX	Stock Options (Right to Buy)	A - Award	D	12,00		19.776		0
2019-11-08	2019-11-06	4	Blackstone Group L.P. See Footnotes	GRTX	Stock Options (Right to Buy)	J - Other	I	12,00		19.776		0
2019-11-08	2019-11-06	4	Fuller Jason	GRTX	Stock Option	A - Award	D	12,00		19.776		19.776
2019-11-06		3	Sorensen Mel	GRTX	Common Stock		D						30.058
2019-11-06		3	Sorensen Mel	GRTX	Common Stock		D						30.058
2019-11-06		3	Sorensen Mel	GRTX	Common Stock		D						30.058
2019-11-06		3	Matthes Catherine L. By Trust	GRTX	Common Stock		I						105.660
2019-11-06		3	Matthes Catherine L. By Trust	GRTX	Common Stock		I						105.660
2019-11-06		3	Matthes Catherine L. By Trust	GRTX	Common Stock		I						105.660
2019-11-06		3	Riley Dennis By Trust	GRTX	Common Stock		I						108.516
2019-11-06		3	Riley Dennis By Trust	GRTX	Common Stock		I						108.516
2019-11-06		3	Riley Dennis By Trust	GRTX	Common Stock		I						108.516
2019-11-06		3	Keene Jeffrey	GRTX	Common Stock		D						108.516
2019-11-06		3	Keene Jeffrey	GRTX	Common Stock		D						108.516
2019-11-06		3	Keene Jeffrey	GRTX	Common Stock		D						108.516
2019-11-06		3	Buckler Regina A.	GRTX	Common Stock		D						108.516
2019-11-06		3	Buckler Regina A.	GRTX	Common Stock		D						108.516
2019-11-06		3	Buckler Regina A.	GRTX	Common Stock		D						108.516
2019-11-06		3	Beardsley Robert A	GRTX	Common Stock		D						105.660
2019-11-06		3	Beardsley Robert A	GRTX	Common Stock		D						105.660
2019-11-06		3	Beardsley Robert A	GRTX	Common Stock		D						105.660

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

GRTX / Galera Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5